MedTrace Logo

PCV13 Impact on Pneumococcal Nasopharyngeal Carriage Study

NCT05114902 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 451

Last updated 2023-09-13

No results posted yet for this study

Summary

Prospective, observational, hospital based, nasopharyngeal carriage (NPC), vaccine effectiveness study Comparisons will be made in Filipino children, aged 8 weeks to ≤60 months of age at enrollment, who have been hospitalized with a radiologically-confirmed, community-acquired pneumonia (CAP).

Conditions

  • Community-acquired Pneumonia

Interventions

DIAGNOSTIC_TEST

Nasopharyngeal swab

A sample obtained from the nasopharynx for detection of live pneumococci and pneumococcal respiratory carriage

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Philippine Children's Medical Center, Philippines

    collaborator UNKNOWN

  • Southern Philippines Medical Center

    collaborator OTHER

  • Asian Foundation for Tropical Medicine Inc.

    lead OTHER

Principal Investigators

  • Marilla G Lucero, MD · Asian Foundation for Tropical Medicine

Eligibility

Min Age
8 Weeks
Max Age
60 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-24
Primary Completion
2023-07-31
Completion
2024-11-30

Countries

  • Philippines

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05114902 on ClinicalTrials.gov